Jade Biosciences Inc. JBIO
$15.81
▼ -4.60% 24H
About
Jade Biosciences Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for inflammation and immunology indications in patients with autoimmune diseases. Its lead candidate, JADE101, is a monoclonal antibody designed to inhibit the cytokine APRIL (A Proliferation-Inducing Ligand) and …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees55
TickerJBIO
Statistics
Market Cap$780.2M
Revenue (TTM)$0
Net Income-$127.4M
Net Margin—
EPS$-3.19
P/E-5.03
P/S—
P/B2.53
EV/EBITDA-3.88
ROE-38.3%
Dividend Yield—
Price$15.81
Data: Twelve Data · Revenue = mcap / P/S